Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
Kaya NA, Tai D, Lim X, Lim JQ, Lau MC, Goh D, Phua CZJ, Wee FYT, Joseph CR, Lim JCT, Neo ZW, Ye J, Cheung L, Lee J, Loke KSH, Gogna A, Yao F, Lee MY, Shuen TWH, Toh HC, Hilmer A, Chan YS, Lim TK, Tam WL, Choo SP, Yeong J, Zhai W.
Kaya NA, et al. Among authors: lim jct.
J Immunother Cancer. 2023 Aug;11(8):e007106. doi: 10.1136/jitc-2023-007106.
J Immunother Cancer. 2023.
PMID: 37586766
Free PMC article.